Abstract

Among the devastating consequences of AIDS has been its epidemic spread in the developing world. The disease has caused unprecedented suffering, debilitation, loss of life and disruption of family, social and economic stability. Because of the considerable expense and logistical difficulty in providing antiviral drugs to populations infected with the human immunodeficiency virus throughout the world, the biomedical community is looking towards vaccines to help solve this compelling problem.

Links

Publisher Full Text

Authors

Nabel GJ

Institution

Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3005, USA. gnabel@nih.gov

Source

Nature 410:6831 2001 Apr 19 pg 1002-7

MeSH

AIDS Vaccines
Adjuvants, Immunologic
Animals
HIV
HIV Antibodies
HIV Antigens
HIV Infections
Humans
T-Lymphocytes, Cytotoxic
Vaccines, Attenuated
Vaccines, Synthetic

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

11309631